StemCellPatents.com Newsletter

Dear manoj kumar valluru,

Last week a patent (#7,393,830) was issued to the Calgary, Canada based company Stem Cell Therapeutics TSX-V:SSS covering the use of prolactin for a) increasing number of neural stem cells; b) increasing neuron formation; and c) increasing neuron formation in the olfactory bulb. Given that this company has a track record of rapidly translating activators of endogenous stem cells into clinical products, it will be interesting to watch this story develop.

We know that some people believe monocytes may have pluripotent activity. The endevours of people in this area were made easier by a patent (#7,393,628) issued last week covering a new way of harvesting monocytes from peripheral blood.

Two interesting news items: the first, a television report of 2 patients with multiple sclerosis who recieved stem cell therapy (the non-myeloablative type) and reported positive effects; the second story, researchers in Houston identified immunogenic epitopes of a leukemia-associated antigen called PRAME, which may be useful in development of a vaccine for CML.

Prolactin induced increase in neural stem cell numbers     Patent Number: 7,393,830 Assignee | Inventor We at StemCellPatents.com believe that the future of stem cell therapy will involve optimization of current therapeutic approaches that are already in clinical trials.  For example, it is known that intravenous administration of mesenchymal stem cells can generate statistically significant improvement in heart...[Read More] Ask a question OR leave your comments.

Stem Cell Therapy of Multiple Sclerosis: Positive Case Reports Sunday July 6th, 2008 @ 17:12:02 EST [Watch the Video]  The use of stem cell therapy for multiple sclerosis has been previously reported in case reports, including from Dr. Simon Slavin's group in Israel.  In multiple sclerosis the rationale for why stem cell therapy would have beneficial effects derives from observations that...[Read More] Ask a question OR leave your comments. Read more StemCellPatents.com News

RECENTLY ADDED PATENTS     Mammary stem cell marker (7,563,619) Assignee | Inventor | Ask a question OR leave your comments     Soft tissue repair and regeneration using postpartum-derived cells (7,560,276) Assignee | Inventor | Ask a question OR leave your comments     Compositions and methods for generating skin (7,560,275) Assignee | Inventor | Ask a question OR leave your comments     Method for reducing neuronal degeneration so as to ameliorate the effects of injury or disease (7,560,102) Assignee | Inventor | Ask a question OR leave your comments     Human cord blood derived unrestricted somatic stem cells (USSC) (7,560,280) Assignee | Inventor | Ask a question OR leave your comments     Human cord blood derived unrestricted somatic stem cells (USSC) (7,556,801) Assignee | Inventor | Ask a question OR leave your comments     Dedifferentiated, programmable stem cells of monocytic origin, and their production and use (7,553,663) Assignee | Inventor | Ask a question OR leave your comments     Stromal antigen-presenting cells and use thereof (7,553,661) Assignee | Inventor | Ask a question OR leave your comments     Directed in vitro differentiation of marrow stromal cells into neural cell progenitors (7,547,545) Assignee | Inventor | Ask a question OR leave your comments     Progenitor cells from wharton's jelly of human umbilical cord (7,547,546) Assignee | Inventor | Ask a question OR leave your comments     View all 1436 Stem Cell Patents on StemCellPatents.com

LATEST NEWS     Leptin Blocks T Regulatory Cell Expansion August 23rd, 2009     Mechanism of Multiple Sclerosis Stem Cell Therapy July 24th, 2009 : 2 Comments     Lithium for Treatment of Multiple Sclerosis July 15th, 2009     Treatment of Degenerative Disc Disease by Bone Marrow Stem Cells July 9th, 2009 : 2 Comments     Apoptotic Cells Secrete Angiogenic Factors June 27th, 2009     Read more news on StemCellPatents.com

LATEST JOBS POSTS     View the StemCellPatents.com Job Board

Thanks again for your help in supporting StemCellPatents.com.

We welcome your comments! Tell us here.

(BETA)